PubRank
Search
About
Peter N Monk
Author PubWeight™ 42.80
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
J Biol Chem
2001
1.80
2
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms.
J Cell Biol
2008
1.75
3
C5L2 is a functional receptor for acylation-stimulating protein.
J Biol Chem
2005
1.69
4
Changes and regulation of the C5a receptor on neutrophils during septic shock in humans.
J Immunol
2013
1.57
5
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation.
Blood
2004
1.56
6
The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis.
J Immunol
2008
1.52
7
Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis.
Glia
2005
1.47
8
The human complement fragment receptor, C5L2, is a recycling decoy receptor.
Mol Immunol
2008
1.45
9
The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.
J Biol Chem
2003
1.41
10
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration.
FASEB J
2006
1.33
11
Complement component 5a (C5a).
Int J Biochem Cell Biol
2009
1.24
12
C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
J Biol Chem
2003
1.22
13
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors.
Pharmacol Rev
2013
1.22
14
Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis.
FASEB J
2012
1.21
15
Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
J Immunol
2005
1.19
16
Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
J Biol Chem
2006
1.17
17
Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.
J Virol
2006
1.15
18
Astrocyte function and role in motor neuron disease: a future therapeutic target?
Glia
2009
1.09
19
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.
J Med Chem
2012
1.04
20
Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
Mol Immunol
2007
1.01
21
Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation.
FASEB J
2003
0.98
22
Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion.
Biochem Biophys Res Commun
2003
0.97
23
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site.
J Biol Chem
2005
0.95
24
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
J Biol Chem
2006
0.95
25
ALS: life and death in a bad neighborhood.
Nat Med
2006
0.90
26
Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.
BioDrugs
2009
0.90
27
The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9.
Cell Mol Life Sci
2011
0.89
28
C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.
J Immunol
2012
0.89
29
Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.
Immunology
2009
0.87
30
Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1.
Neuroreport
2009
0.86
31
A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function.
BMC Neurosci
2011
0.85
32
The role of tetraspanins in fusion.
Biochem Soc Trans
2011
0.84
33
Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
Int Immunopharmacol
2009
0.84
34
Cooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cells.
Infect Immun
2011
0.82
35
Interspecies contamination of the KM3 cell line: implications for CD63 function in melanoma metastasis.
Int J Cancer
2003
0.79
36
Characterisation of C5a receptor agonists from phage display libraries.
Biochem Pharmacol
2003
0.78
37
Complement C5a receptors in the pituitary gland: expression and function.
J Endocrinol
2008
0.78
38
Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia.
Amyotroph Lateral Scler
2011
0.76
39
Wild-type but not mutant SOD1 transgenic astrocytes promote the efficient generation of motor neuron progenitors from mouse embryonic stem cells.
BMC Neurosci
2013
0.75